All patients (n = 423) | Good outcomes (n = 231) | Poor outcomes (n = 192) | P-value | |
---|---|---|---|---|
[year, M (Q1, Q3)] | 70(62,77) | 68(58,75) | 74(66,78) | < 0.001 |
Male [n, (%)] | 250(59.1) | 154(66.7) | 96(50.0) | 0.001 |
Medical history [n, (%)] | ||||
Hypertension | 269(63.6) | 134(58.0) | 135(70.3) | 0.009 |
Diabetes mellitus | 59(13.9) | 26(11.3) | 33(17.2) | 0.080 |
Atrial fibrillation | 221(52.2) | 97(42.0) | 124(64.6) | < 0.001 |
Antiplatelets/anticoagulants history [n, (%)] | 0.523 | |||
No | 340(80.4) | 188(81.4) | 152(79.2) | |
Antiplatelets | 58(13.7) | 28(12.1) | 30(15.6) | |
Anticoagulants | 25(5.9) | 15(6.5) | 10(5.2) | |
IT [n, (%)] | 53(12.1) | 28(12.1) | 23(12.0) | 0.964 |
Baseline SBPa[mmHg, M (Q1, Q3)] | 152(139,168) | 150(138,165) | 156(140,172) | 0.033 |
Baseline DBPb[mmHg, M (Q1, Q3)] | 83(74,92) | 83(74,92) | 82(74,93) | 0.708 |
Admission NIHSS [M (Q1, Q3)] | 14(11,17) | 12(10,15) | 15(12,19) | < 0.001 |
Admission ASPECT [M (Q1, Q3)] | 9(7,10) | 9(8,10) | 8(6,9) | < 0.001 |
TOAST classification [n, (%)] | < 0.001 | |||
LAA | 119(28.1) | 87(37.7) | 32(16.7) | |
Cardioembolic | 257(60.8) | 116(50.2) | 141(73.4) | |
Others | 47(11.1) | 28(12.1) | 19(9.9) | |
Occlusion location [n, (%)] | 0.036 | |||
ICA | 164(38.8) | 78(33.8) | 86(44.8) | |
MCA(M1) | 216(51.1) | 131(56.7) | 85(44.3) | |
MCA(M2) | 43(10.2) | 22(9.5) | 21(10.9) | |
OTP [min, M (Q1, Q3)] | 300(230,390) | 300(221,360) | 300(240,392) | 0.424 |
OTRc [min, M (Q1, Q3)] | 356(280,456) | 350(270,454) | 360(300,493) | 0.105 |
Collateral scored [n, (%)] | < 0.001 | |||
Grade 0 | 49(11.6) | 5(2.2) | 44(22.9) | |
Grade 1 | 101(24.0) | 43(18.8) | 58(30.2) | |
Grade 2 | 271(64.4) | 181(79.0) | 90(46.9) | |
mTICI,2b/3 [n, (%)] | 379(89.6) | 216(93.5) | 163(84.9) | 0.004 |
SHR [M (Q1, Q3)] | 0.87(0.76,1.05) | 0.83(0.72,0.94) | 0.97(0.83,1.13) | < 0.001 |
GG [M (Q1, Q3)] | − 0.84 (-1.67,0.33) | -1.81(-1.07,-0.50) | -1.26 (-0.17,0.86) | < 0.001 |
SHR (> 0.89) [n, (%)] | 191(45.2) | 69(29.9) | 122(63.5) | < 0.001 |
GG (>-0.53) [n, (%)] | 169(40.0) | 59(25.5) | 110(57.3) | < 0.001 |